Skip to content

Drug interactions

Danicopan + Lapatinib

Severity: Moderate

Danicopan and Lapatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Danicopan inhibits P-glycoprotein and BCRP, both involved in lapatinib transport. Lapatinib exposure may therefore increase, raising the risk of diarrhea, hepatotoxicity and QT prolongation.

What this interaction means in plain words

Danicopan and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Danicopan belongs to Miscellaneous; Lapatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Danicopan inhibits P-glycoprotein and BCRP efflux transporters, increasing lapatinib absorption.

What to do

Monitor for lapatinib toxicity, including liver tests and ECG, and consider a lapatinib dose reduction if adverse effects emerge.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Danicopan and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Danicopan with Lapatinib?

MediHelp rates the interaction as moderate. Danicopan and Lapatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Danicopan inhibits P-glycoprotein and BCRP, both involved in lapatinib transport. Lapatinib exposure may therefore increase, raising the risk of diarrhea, hepatotoxicity and QT prolongation.

How serious is the interaction between Danicopan and Lapatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for lapatinib toxicity, including liver tests and ECG, and consider a lapatinib dose reduction if adverse effects emerge.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in